Adding once-daily lixisenatide for type 2 diabetes inadequately controlled by established basal insulin: a 24-week, randomized, placebo-controlled comparison (GetGoal-L)
IGF-1 and the muscle question The biggest worry with rapid weight loss is that some of what you lose is muscle, not fat
Readers should verify all details directly with MEDVi, their healthcare provider, and relevant regulatory resources before making decisions
The pain-relieving aspect appears secondary to tissue repair rather than direct analgesic action
Enzo Spisni, [email protected] These authors have contributed equally to this work $ These authors have contributed equally to this work and share last authorship ORCID: Fabio Vivarelli, orcid.org/0000-0002-8734-0985 Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers